A short summary of the PPI opportunities across the NCRI Partnership…
NCRI Annual Review 2019-20
'A review of NCRI’s key activities and accounts for the financial year 2019-20…
Radiotherapy Trial Set-up in the UK: Identifying Inefficiencies and Potential Solutions
'Radiotherapy clinical trials are integral to the development of new treatments to improve the outcomes of patients with cancer.…
Latest radiotherapy news from NCRI
'CTRad 10-year celebration at the 2019 NCRI Conference As part of CTRad’s 10-year anniversary celebrations, a session was hosted at…
Living With and Beyond Cancer: Top Research Priorities in the UK
'As presented at the 34th German Cancer Conference 2020…
CTRad 10 Years On: From 10-point Plan to Top 10 Achievements
'The UK Clinical and Translational Radiotherapy Research Working Group (CTRad) was established in 2009 by the National Cancer Research Institute (NCRI) and its funding partners, in response to reviews of the radiotherapy research landscape in 2003 [1] and 2008 [2], which had identified radiation biology and oncology as areas of unmet need.…
A Review of International Biobanks and Networks’ publication in the Biopreservation and Biobanking Journal (PDF)
'As ISBER celebrates its 20th anniversary, we should be drawn to critically examine our past biobanking initiatives to assess the merits of their achievement and to learn for our future.…
The Challenge Facing Academic Radiotherapy Physics in the UK
'Medical physics has been central to the scientific and technical development of radiotherapy since its inception as a treatment modality for cancer patients.…
NCRI Annual Review 2018-19
'A review of NCRI’s key activities and accounts for the financial year 2018-19…
CTRad Radiotherapy DDRi Combinations Workshop
'This whole day meeting brought together just under 80 people: scientists from academia and industry, statisticians, clinicians, patient advocates and funding bodies with all their different experience and perspectives on the issues surrounding combining DDR inhibitors (DDRi) with radiotherapy.…
Systematic review of methodology used in clinical studies evaluating the benefits of proton beam therapy
'Proton beam therapy (PBT) delivers high-energy radiation to target tumours while sparing surrounding normal tissues. The dosimetric advantages of PBT over traditional photon radiotherapy may be clear but the translation of this benefit into clinically meaningful reductions in toxicities and improved quality-of-life (QoL) needs to be determined.…
CM-Path consensus statement published in the BJC on the development and implementation of molecular diagnostic tests in the United Kingdom
'Pathology has evolved from a purely morphological description of cellular alterations in disease to our current ability to interrogate tissues with multiple ‘omics’ technologies. By utilising these techniques and others, ‘molecular diagnostics’ acts as the cornerstone of precision/personalised medicine by attempting to match the underlying disease mechanisms to the most appropriate targeted therapy.…